4.8 Article

Pathologists' first opinions on barriers and facilitators of computational pathology adoption in oncological pathology: an international study

Journal

ONCOGENE
Volume 42, Issue 38, Pages 2816-2827

Publisher

SPRINGERNATURE
DOI: 10.1038/s41388-023-02797-1

Keywords

-

Ask authors/readers for more resources

Computational pathology (CPath) algorithms can detect, segment, or classify cancer in whole slide images with accuracy comparable to or higher than pathologists. However, there are challenges to be overcome before these algorithms can be used in practice. International perspectives were explored through an eSurvey and interviews, revealing variations in opinions and experiences regarding barriers and facilitators. This diversity highlights the need for further quantitative research to determine important factors for adoption and initiate validation studies.
Computational pathology (CPath) algorithms detect, segment or classify cancer in whole slide images, approaching or even exceeding the accuracy of pathologists. Challenges have to be overcome before these algorithms can be used in practice. We therefore aim to explore international perspectives on the future role of CPath in oncological pathology by focusing on opinions and first experiences regarding barriers and facilitators. We conducted an international explorative eSurvey and semi-structured interviews with pathologists utilizing an implementation framework to classify potential influencing factors. The eSurvey results showed remarkable variation in opinions regarding attitude, understandability and validation of CPath. Interview results showed that barriers focused on the quality of available evidence, while most facilitators concerned strengths of CPath. A lack of consensus was present for multiple factors, such as the determination of sufficient validation using CPath, the preferred function of CPath within the digital workflow and the timing of CPath introduction in pathology education. The diversity in opinions illustrates variety in influencing factors in CPath adoption. A next step would be to quantitatively determine important factors for adoption and initiate validation studies. Both should include clear case descriptions and be conducted among a more homogenous panel of pathologists based on sub specialization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available